title: Carboplatin-allergic patients undergoing desensitization: prevalence and impact of the BRCA 1/2 mutation.
authors.affiliation: Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Mass; Division of Clinical Immunology and Allergy, University of São Paulo Medical School, São Paulo, Brazil.
authors.forename: Violeta Régnier
authors.initials: VR
authors.lastname: Galvão
authors.affiliation: Division of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Tenn; Institute for Immunology and Infectious diseases, Murdoch University, Perth, Australia.
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Phillips
authors.affiliation: Division of Clinical Immunology and Allergy, University of São Paulo Medical School, São Paulo, Brazil.
authors.forename: Pedro
authors.initials: P
authors.lastname: Giavina-Bianchi
authors.affiliation: Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Women's Hospital, Boston, Mass. Electronic address: mcastells@partners.org.
authors.forename: Mariana C
authors.initials: MC
authors.lastname: Castells
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D008875:Middle Aged; D019313:BRCA1 Protein / Q000235:genetics; D024682:BRCA2 Protein / Q000235:genetics; D016190:Carboplatin / Q000009:adverse effects / Q000276:immunology / Q000627:therapeutic use; D003888:Desensitization, Immunologic / Q000379:methods; D004342:Drug Hypersensitivity / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D009154:Mutation / Q000235:genetics; D010051:Ovarian Neoplasms / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D015995:Prevalence; D012306:Risk; D014481:United States / Q000453:epidemiology
chemical_list: D019313:BRCA1 Protein; D024682:BRCA2 Protein; D016190:Carboplatin